ARCHIVES

DCBD To Increase Emphasis On Workshops, Cut Program Initiatives

This article is from The Cancer Letter archive.

Vol. 11 No. 43 | November 8, 1985

Download PDF Visit The Full Archive

Related Articles

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

IOM To Advise Army On Spending $210 Mil. Breast Cancer Money

January 8, 1993

Study Suggests Surveillance Colonoscopies Overperformed

August 27, 2004

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

April 17, 2009

Nexavar Improves PFS In Phase III Trial

January 25, 2013

Colorado Center Delays New Core Grant Application

July 13, 1979